These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9777746)

  • 61. Thyroid imaging using positron emission tomography--a comparison with ultrasound imaging and conventional scintigraphy in thyrotoxicosis.
    Flower MA; Irvine AT; Ott RJ; Kabir F; McCready VR; Harmer CL; Sharma HL; Smith AG
    Br J Radiol; 1990 May; 63(749):325-30. PubMed ID: 2198979
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Radioiodine uptake following iodine-131 therapy for Graves' disease: an early indicator of need for retreatment.
    Carpentier WR; Gilliland PF; Piziak VK; Petty FC; McConnell BG; Verdonk CA; Ibarra JD; Thompson JQ
    Clin Nucl Med; 1989 Jan; 14(1):15-8. PubMed ID: 2714035
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dose-response study on thyrotoxic patients undergoing positron emission tomography and radioiodine therapy.
    Flower MA; al-Saadi A; Harmer CL; McCready VR; Ott RJ
    Eur J Nucl Med; 1994 Jun; 21(6):531-6. PubMed ID: 8082669
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [The 20 min. iodine uptake in Graves' disease. 1. Technique and reliability (author's transl)].
    Wilkin TJ; Crooks J; Jaffiol C; Baldet L
    Ann Endocrinol (Paris); 1980; 41(5):363-9. PubMed ID: 6894521
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Heat shock protein 60 mRNA is not increased in Graves' disease thyroid tissue.
    Trieb K; Amberger A; Sztankay A
    Endocr Res; 1996 May; 22(2):185-93. PubMed ID: 8799697
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Measurement of radiation dose to the thyroid using positron emission tomography.
    Ott RJ; Batty V; Webb BS; Flower MA; Leach MO; Clack R; Marsden PK; McCready VR; Bateman JE; Sharma H
    Br J Radiol; 1987 Mar; 60(711):245-51. PubMed ID: 3494482
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Study of the correlation between administered activity and radiation committed dose to the thyroid in 131I therapy of Graves' disease.
    Traino AC; Di Martino F; Lazzeri M; Stabin MG
    Radiat Prot Dosimetry; 2001; 95(2):117-24. PubMed ID: 11572639
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Regional stimulation of thyroid epithelial cells in Graves' disease by lymphocytic aggregates and plasma cells.
    Paschke R; Brückner N; Eck T; Schaaf L; Back W; Usadel KH
    Acta Endocrinol (Copenh); 1991 Nov; 125(5):459-65. PubMed ID: 1759536
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Tomographic imaging of the human thyroid using 124I.
    Frey P; Townsend D; Flattet A; De Gautard R; Widgren S; Jeavons A; Christin A; Smith A; Long A; Donath A
    J Clin Endocrinol Metab; 1986 Oct; 63(4):918-27. PubMed ID: 3488999
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Fully automated computer-aided volume estimation system for thyroid planar scintigraphy.
    Huang JY; Lin KJ; Chen YS
    Comput Biol Med; 2013 Oct; 43(10):1341-52. PubMed ID: 24034725
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Two-step radioiodine therapy in benign thyroid diseases during a single hospital visit--observations on 100 patients].
    Khandani A; Schicha H
    Nuklearmedizin; 1999; 38(5):140-3. PubMed ID: 10488480
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Analysis of risk factors of rapid thyroidal radioiodine-131 turnover in Graves' disease patients.
    Zhang R; Tan J; Wang R; Zhang G; Jia Q; Meng Z; Zhang Y
    Sci Rep; 2017 Aug; 7(1):8301. PubMed ID: 28811561
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Standardized Uptake Value Using Thyroid Quantitative SPECT/CT for the Diagnosis and Evaluation of Graves' Disease: A Prospective Multicenter Study.
    Dong F; Li L; Bian Y; Li G; Han X; Li M; Liu J; Xue Y; Li Y; Hu Y; Tan J
    Biomed Res Int; 2019; 2019():7589853. PubMed ID: 30834273
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of
    Happel C; Kranert WT; Gröner D; Baumgarten J; Halstenberg J; Bockisch B; Sabet A; Grünwald F
    Endocrine; 2021 Jul; 73(1):125-130. PubMed ID: 33439464
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Elevated F-18 FDG uptake in the thymus in Graves' disease.
    Chen YK; Chen YL
    Clin Nucl Med; 2003 Feb; 28(2):142-3. PubMed ID: 12544139
    [No Abstract]   [Full Text] [Related]  

  • 76. Evaluation of Glucose Uptake in Normal and Cancer Cell Lines by Positron Emission Tomography.
    Maddalena F; Lettini G; Gallicchio R; Sisinni L; Simeon V; Nardelli A; Venetucci AA; Storto G; Landriscina M
    Mol Imaging; 2015; 14():490-8. PubMed ID: 26461458
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [The mechanism of glucose intolerance in patients with Graves' disease].
    Kondo Y; Suzuki S; Gomi Y; Mayumi K; Sakamaki T; Inoue T; Iino S
    Nihon Naibunpi Gakkai Zasshi; 1992 Dec; 68(12):1257-68. PubMed ID: 1291337
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Painful thyroid gland: an atypical presentation of Graves' disease.
    Stanley JM; Najjar SS
    Clin Endocrinol (Oxf); 1992 Nov; 37(5):468-9. PubMed ID: 1486697
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Concept and validation of a simple model of the intrathyroidal iodine kinetics].
    Rink T; Bormuth FJ; Braun S; Zimny M; Schroth HJ
    Nuklearmedizin; 2004 Feb; 43(1):21-5. PubMed ID: 14978537
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Glucose metabolism and rate constants in Alzheimer's disease examined with dynamic positron emission tomography scan.
    Fukuyama H; Kameyama M; Harada K; Nishizawa S; Senda M; Mukai T; Yonekura Y; Torizuka K
    Acta Neurol Scand; 1989 Oct; 80(4):307-13. PubMed ID: 2816287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.